Company press releases

Company press releases

10-11-2017

Elanix Biotechnologies AG: Announces Subscription Price for New Shares in Capital Increase

29-09-2017

Elanix Biotechnologies Announces First Half 2017
Financial Results

20-09-2017

Elanix Biotechnologies Subsidiary Signs Wholesale & Logistics Agreement in Europe to Support Expanding Commercialization of GYNrepair®

20-07-2017

Elanix Biotechnologies’s Partner Transwell Biotech Starts First Clinical Study with Progenitor Cell Treatment for Skin Graft Wounds First Patient Treated in Phase I/II TWB-103 Trial

27-06-2017

Elanix Biotechnologies Launches Adherence App for GYNrepair® Women’s Intimate Health Cream

31-05-2017

Elanix Biotechnologies Starts EU Commercialization of GYNrepair® Cream for Women’s Intimate Relief

31-05-2017

Elanix Biotechnologies lance la commercialisation en Europe de la crème GYNrepair® pour le soulagement intime des femmes

21-04-2017

Elanix Signs Agreement with Apraxon to Establish European Logistics Center

16-03-2017

Elanix Acquires Third Cell Based Bioactive Cream Formulation with Potential to Alleviate a Significant Chronic Dermatological Condition

13-01-2017

Elanix Biotechnologies AG: CEO informs about planned cash capital increase with indirect subscription rights

22-11-2016

Elanix Biotechnologies AG announces non-binding letter of intent with Oxford MEStar Ltd. in regard to setting up a JV to market GynRepair in China

Press Releases

Potsdam, November 22, 2016 – Elanix Biote [...]

22-11-2016

Elanix生物技术有限公司(Elanix Biotechnologies AG)宣布与牛津医工有限公司(Oxford MEStar Ltd.)就成立合资公司以进行GynRepair® 在中国的销售 签署无约束力意向书

Press Releases

德国波茨坦, 2016年11月22日 – Elan [...]

08-11-2016

ELANIX BIOTECHNOLOGIES AG STRATEGIC PARTNER, TRANSWELL BIOTECHNOLOGY LTD., RECEIVES US FDA CLEARANCE FOR PHASE I/II CLINICAL TRIAL USING FIBROBLAST PROGENITORS TWB-103

Press Releases

Nyon, Switzerland and Potsdam, Germ [...]

25-10-2016

ELANIX BIOTECHNOLOGIES AG, KEY PATENT FOR THE PREPARATION OF PARENTAL CELL BANK GRANTED IN THE U.S.A.

Press Releases

Nyon, Switzerland and Potsdam, Germany, [...]

30-09-2016

ELANIX BIOTECHNOLOGIES AG subsidiary acquires 100% of equity of Repair-A SA

Press Releases

Nyon, Switzerland and Potsdam, Germany, [...]

01-09-2016

ELANIX BIOTECHNOLOGIES AG Securing Funding, Adding Staff and Moving to Larger Offices

Press Releases

Nyon, Switzerland and Potsdam, Germany, Septemb [...]